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The catalytic properties of some selected enzymes have long been exploited to
carry out efficient and cost-effective bioconversions in a multitude of research and
industrial sectors, such as food, health, cosmetics, agriculture, chemistry, energy,
and others. Nonetheless, for several applications, naturally occurring enzymes are
not considered to be viable options owing to their limited stability in the required
working conditions. Over the years, the quest for novel enzymes with actual
potential for biotechnological applications has involved various complementary
approaches such as mining enzyme variants from organisms living in extreme
conditions (extremophiles), mimicking evolution in the laboratory to develop more
stable enzyme variants, and more recently, using rational, computer-assisted
enzyme engineering strategies. In this review, we provide an overview of the most
relevant enzymes that are used for industrial applications and we discuss the strate-
gies that are adopted to enhance enzyme stability and/or activity, along with some
of the most relevant achievements. In all living species, many different enzymes
catalyze fundamental chemical reactions with high substrate specificity and rate
enhancements. Besides specificity, enzymes also possess many other favorable
properties, such as, for instance, cost-effectiveness, good stability under mild pH
and temperature conditions, generally low toxicity levels, and ease of termination
of activity. As efficient natural biocatalysts, enzymes provide great opportunities to
carry out important chemical reactions in several research and industrial settings,
ranging from food to pharmaceutical, cosmetic, agricultural, and other crucial
economic sectors. VC 2018 Author(s). All article content, except where otherwise
noted, is licensed under a Creative Commons Attribution (CC BY) license (http://
creativecommons.org/licenses/by/4.0/). https://doi.org/10.1063/1.4997367
I. THERMOSTABLE ENZYMES IN INDUSTRIAL APPLICATIONS
Enzymes have long been used in detergents and for food production, especially cheese,
sourdough, beer, and wine as well as for the production of leather, indigo, and linen.1,2 Such
processes are usually triggered by enzymes produced by specific microorganisms or by enzymes
that are present in natural products, such as, for instance, the papaya fruit, hence, not used as
pure isolated molecules. The development of fermentation processes has allowed the large-scale
production, isolation, and purification of enzymes from selected production strains, thus making
it possible to provide biocatalysts to be used as molecular tools in actual industrial processes,
such as, for instance, in detergent, textile, and starch industries. In particular, a commercial
breakthrough occurred in 1957 with the first commercial protease production by Novozymes.1
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More recent advancements in protein engineering and directed evolution have made the
continuous development of new and more efficient enzymes a reality. Indeed, mutant enzymes
for established technical applications or new tailor-made enzymes for areas of application
where enzymes had not been previously used have been successfully introduced. Of those
enzymes that are used in industrial processes, over half are from fungi, over one-third is from
bacteria, and the rest originate from animal (8%) and plant (4%) sources.3 Recombinant DNA
techniques have allowed the isolation and cloning of genes encoding for enzymes from all pos-
sible sources, including microbes and other microorganisms that are particularly difficult to
manipulate, and high-yield heterologous protein expression. As a result, this convenient technol-
ogy has increased production levels and has shifted enzyme production from bacterial strains
that are not suited for industry into industry-friendly microorganisms such as Aspergillus,
Trichoderma, Kluyveromyces, Saccharomyces, Yarrowia, and Bacillus.4
On a large scale, the enzymes produced by microbial strains are economical due to high
production levels associated with standard expression, ease of growth, inexpensive culture
media, and short fermentation cycles. Downstream processing allows for a rapid examination of
thousands of cultures. Furthermore, different microbes produce somewhat different enzymes
that catalyze the same reaction, providing high levels of flexibility.
The International Union of Biochemistry (IUB) categorizes enzymes in six different clas-
ses, based on the enzyme action mechanism. The six enzyme classes are ligases, isomerases,
oxidoreductases, lyases, transferases, and hydrolases. Currently, more than 75% of the enzymes
that are used commercially are members of the hydrolase family and are employed for the deg-
radation of a number of different natural substances. Of all the commercial hydrolases, pro-
teases are the major and most important sub-type. Indeed, they are widely used in both the
detergent industry and the starch industry. Proteases are also important components in textile,
animal feed, and dairy industries. The second largest sub-group is represented by carbohydrases,
mostly amylases and cellulases. For instance, carbohydrases are extensively used in productive
sectors such as starch, textile, detergent, and baking industries, which is where most industrial
enzymes are used.
It has been estimated that by 2018, the global market for industrial enzymes will surpass
the USD 7.1 billion mark and its five-year compound annual growth rate (CAGR) will be
around 8.2%. The market for food enzymes alone is projected to reach USD 2.94 billion by
2021, at a CAGR of 7.4% between 2016 and 2021. Moreover, it is expected that the maximum
growth rate will be observed in the detergent enzyme segment (CAGR of 11.3% in the
2016–2021 period).5 Proteases were the prominent product segment in 2015, accounting for
27.4% of the global enzyme market; now, they are expected to show an even more profitable
growth in light of their increasing application in pharmaceutical, detergent, and chemical sec-
tors.6 The most relevant industrial applications of enzymes are summarized in Table I.
At the industrial level, enzymes are mostly used as detergent additives. Indeed, detergents
are supplemented with proteases, lipases, amylases, oxidases, peroxidases, and cellulases in
order to breakdown different types of chemical bonds in water. To this end, it is essential that
they maintain their activity at high temperatures (60 C) and high pH values (pH 9–11), in par-
ticular when mixed with other washing powder components. Nearly 25% of the total worldwide
sales of enzymes is represented by proteases that are added to laundry detergents. In Secs.
I A–I H, the most important families of industrially relevant enzymes are described, together
with key applications.
A. Pectinases
In paper and textile industries, enzymes are increasingly utilized not only to develop
cleaner processes but also to reduce both raw material usage and waste production. For
instance, an enzymatic process based on a pectate lyase that allows the low-temperature
removal of pectin and other hydrophobic materials from cotton fabrics has been developed.7
The food industry also takes advantage of pectinases, particularly for the clarification of fruit
juices, for the degumming of fibers, and for wine making.
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TABLE I. The most relevant industrial applications of bacterial/fungal enzymes: in the first column, the enzyme name is
specified, followed by its International Union of Biochemistry (IUB) class, the typical substrate, and its main applications.
The IUB classes are Oxido-Reductases (1), Transferases (2), Hydrolase (3), Lyases (4), Isomerases (5), and Ligases (6).
Enzyme
IUB
classes Substrate classes Industry field (application)
a-amylase (or
glycogenase)
3 Carbohydrates Baking (softness and volume of bread), laundry and
detergents (starch strain removal), paper and pulp (deink-
ing, drainage improvement, and starch coating), starch
and fuel (starch liquefaction and saccharification), textile
(removal of starch from woven fabrics and de-sizing),
and food (juice treatments, low calorie beer, glucose, and
fructose syrup production)
a-galactosidase 3 Glycolipids and glycoproteins Dairy
b-glucanase 3 Glucose polysaccharide Animal feed (digestibility improvement) and food
(mashing)
Acetolactate-
decarboxylase
4 (S)-2-hydroxy-2-methyl-3-oxo-
butanoate (C-C bond)
Food (beer maturation)
Acylase 3 Penicillin Organic synthesis (synthesis of semisynthetic penicillin)
Amyloglucosidase 3 Maltooligo- and polysaccharides Personal care (antimicrobial combined with glucose oxi-
dase) and starch and fuel (saccharification)
Asparaginase 3 Asparagine Pharmaceutical (treatment of acute leukemia) and food
(decrease acrylamide)
Catalase 1 Hydrogen peroxide Food and textile (bleach termination)
Cellulase 3 Cellulose and related
polysaccharides
Plant waste treatment, paper and pulp (modification of
fibers, deinking, and drainage), textile (denim finishing
and softening of cotton), cleaning (removal of stains),
color clarification, and anti-redeposition
Cyclodextrin-
glycosyltransferase
2 Cyclic dextrins (starting from
polysaccharides)
Cyclodextrin production
Dextranase 3 Dextran Pharmaceutical and food
Glucose isomerase 5 D-glucose and D-xylose Starch and fuel and fructose syrup (glucose to fructose
conversion)
Glucose oxidase 1 Glucose Baking (strengthening of dough) and personal care
(bleaching and antimicrobial)
Invertase 3 Sucrose Food
Lactase 3 Lactose Food (juice clarification, beer flavor, cork stopper treat-
ment, and milk lactose removal) and textile (bleaching)
Lipase 3 Lipids Baking (stability of dough and conditioning), food
(cheese flavoring), laundry and detergents (lipid stain
removal), textile (de-inking, de-pickling, and cleaning),
organic synthesis (resolution of chiral alcohols and
amides), fats and oils (transesterification and de-
gumming, lysolecithin production for phospholipases),
and paper and pulp (pitch control and contaminant
control)
Lipoxygenase 1 Polyunsaturated fatty acids Baking (bread whitening and dough strengthening)
Mannase 3 b-mannose, galactomannan, and
galactose
Laundry and detergent (reappearing stain removal) and
animal feed additive
Naringinase 3 Naringin (flavanone-7-O-
glycoside)
Food
Nitrilase 3 Nitriles Organic synthesis (synthesis of enantiopure carboxylic
acids)
Oxidoreductases 1 Various compounds: catalyzing
the removal of hydrogen atoms
and electrons
Food and detergents
Pectinase 3 Pectin Food (clarification, mashing, and de-pectinization of
fruit-based products) and textile (scouring)
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B. Cellulases
Cellulose is a renewable resource with great potential for bioconversion to value-added
bioproducts. Cellulose can be degraded by cellulases produced by cellulolytic bacteria.
Cellulases are among some of the most important industrial enzymes known to date.8 For
instance, they convert cellulose to sugars that are suitable for human consumption. On a large
scale, these sugars can in turn be fermented to generate bioethanol and biobased products.8
Cellulases also find application in the textile industry, where they are used for the polishing of
fabrics, and in the laundry detergent industry.9 A cellulase from Streptomyces thermoviolaceus
with high thermal and pH stabilities has been shown to be more active than other commercial
cellulases in the presence of detergents.10
C. Xylanases
Xylanases play a key role in the enzymatic depolymerization of hemicellulose to yield
monomeric sugars. Traditionally, these enzymes are used in food and paper industries. In recent
years, they have received growing attention for the production of sugars from lignocelluloses.
Xylanases are also used for the bleaching of rice straw pulp.11 Xylanases from Actinomadura
sp. FC7 and Nonomuraea flexuosa have been shown to have high thermostability.12,13 Owing to
their high thermal and pH stabilities, fused xylanases from fungi and actinomycetes have been
used in paper and pulp industries.14 Streptomyces spp. are able to produce high levels of xyla-
nase and provide efficient biobleaching.11 Similarly, they are able to hydrolyze straw waste and
produce biogas.15
D. Amylases
Common applications for this family of enzymes are in bakery, brewing, and alcohol indus-
tries, where thermophilic and acidophilic amylases from Streptomyces erumpens are utilized.16,17
Thermostable amylases from Nocardiopsis sp. are also used in bakery and paper industries.18
The amylase from Thermobifida sp. is used for the production of maltotriose from starch.19
TABLE I. (Continued.)
Enzyme
IUB
classes Substrate classes Industry field (application)
Pectin methyl
esterase
3 Pectin Food (firming fruit-based products)
Penicillin amidase 3 Penicillin Pharmaceutical
Phytase 3 Phytic acid Animal feed (phytate digestibility-phosphorous release)
Peroxidase 1 Hydrogen peroxide and
hydroperoxides
Textile (removal of excess dye) and personal care
(antimicrobial)
Protease 3 Protein and peptide Laundry and detergents (protein stain removal), baking,
food (cheese making, milk clotting, low allergenic infant
products, flavor, and brewing for clarification-low calorie
beer), leather (de-hiding), pharmaceutical (treatment of
blood clot), textile (unhearing and bating), paper and pulp
(biofilm removal), and fuel (yeast nutrition)
Pullulanase 3 Polysaccharide Baking, Starch, and Fuel (saccharification)
Rennin 3 Protein (k-casein) Food (precipitation and curd formation in cheese-making)
Subtilisin 3 Protein and peptide Pharmaceutical, laundry, and detergents
Transglutaminase 2 Protein and peptide Baking (laminated dough strengths) and food (modifica-
tion of visco-elastic properties)
Xylanase 3 Polysaccharide b-1,4-xylan Baking (conditioning of dough), paper and pulp (bleach
boosting), animal feed (digestibility improvement), and
starch and fuel (viscosity reduction)
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Moreover, in the starch processing industry, a number of other end product-specific amylases are
commonly used for the synthesis of different maltooligosaccharides.20 Finally, several actinomy-
cetes are the source of cold-active a-amylases that find application in textile, detergent, and bioe-
thanol industries.21
E. Proteases
Proteases are utilized in the dairy industry for the manufacturing of cheese. Due to its high
specificity, calf rennin has generally been the protease of choice in cheese-making. However,
rennin is gradually giving way to microbial proteases from microorganisms such as Mucor mie-
hei, Bacillus subtilis, Endothia parasitica, and Aspergillus oryzae MTCC 5341. Among pro-
teases, aminopeptidase hydrolyzes amino acid residues from the N-terminal portions of proteins.
Aminopeptidases have a wide range of applications in various fields such as the pharmaceutical
industry, where they represent an important molecular tool for protein sequence analysis,22 and
the food industry, for flavor enhancement.23,27 When combined with other proteases, they lead
to a complete degradation of proteins, such as casein, gluten, collagen, and gelatin, helping in
nutrient utilization.24
F. Lipases
Lipases hydrolyze long chain triglycerides to form diglycerides, monoglycerides, fatty acids,
and glycerol.25,31 Besides their ability to hydrolyze carboxylic ester bonds, lipases can catalyze
esterification reactions in non-aqueous media. Lipases find application in food, detergent, phar-
maceutical, leather, textile, cosmetic, and paper industries.26,27 In the food industry, lipases are
used for fat and oil processing. Interestingly, lipases from different organisms provide different
positional specificities, fatty acid specificities, thermal stabilities, and optimum pH values.26
Detergent formulations also include lipases, which are of great help for the removal of lipid
stains, fatty food stains, and sebum from fabrics. Alkaline yeast lipases can work at lower tem-
peratures than bacterial and mold lipases. Cold-active lipases are used as components of deter-
gents for cold washing, with clear advantages in both energy consumption and textile durability.
G. Laccases
Laccases are blue multicopper oxidases that participate in the degradation of polymers and
ring cleavage of aromatic compounds. Owing to their ability to oxidize lignin-related com-
pounds and highly resistant environmental pollutants, they are used in several biotechnological
processes such as for instance wastewater treatment and detoxification. Their typical substrates
are amines and phenols. These enzymes are also used as medical diagnostic tools and biosen-
sors, in biofuel cells, for the bioremediation of herbicide- and pesticide-contaminated soil, as
cleaning agents in water purification systems, as catalysts in drug manufacturing, and as ingre-
dients in cosmetics.28,29
H. Phytases
Phytases are used both as an animal feed ingredient and in foods to improve plant phospho-
rus uptake by animals.30 Phytases allow the release of phosphorus from plant feedstuffs, where
about 2/3 of phosphorus is stored as phytate. Hydrolysis of phytate blocks the translocation of
phosphorous into the soil, where it causes eutrophication. In the food industry, phytases are uti-
lized to remove phytic acid. These enzymes are found in many bacteria, yeasts and fungi. New
fungal phytases showing high specificity or thermostability have also been identified.31
II. THERMOSTABLE ENZYMES IN NATURE
A. Extremozymes
Thermophiles are organisms that have evolved to strive in extreme conditions such as tem-
peratures ranging up to 120 C, high pressure values (up to 250 atm), or extreme pH or salt
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conditions (up to 5% of NaCl).32 Their cellular components are also thermostable, including
their enzymes, sometimes referred to as extremozymes, which are known to withstand high
temperature and extremely acidic and alkaline conditions, and they generally exhibit increased
resistance to denaturation33 and proteolysis.34 Thermophiles have long been considered of high
industrial importance for their possible use in many technological processes, either as intact
organisms or as a source of thermostable enzymes that can catalyze specific reactions at high
temperatures. However, the majority of enzymes that are currently used in industry are obtained
from fungi or mesophilic bacteria. To date, only a few extremozymes have been used for industrial
applications, mostly involving DNA polymerase. Today, beside their use in DNA replication, new
challenges have broadened their range of successful utilization. One of the major problems in the
use of functional extremozymes is the establishment of proper and fine-regulated production condi-
tions such as hosts, efficient transformation approaches, and adequate expression vectors. Due to
differences in codon usage with respect to commonly used expression systems such as Escherichia
coli or Bacillus sp., only a few systems have been successfully utilized, mostly members of the
genus Thermus or the hyperthermophilic species Sulfolobus solfataricus.35,36
B. Thermophiles used in industry
There is hardly any example that can represent the impact of thermophiles in all aspects of
our daily life better than the thermostable DNA polymerases that are used in the polymerase
chain reaction (PCR). Nearly two and a half decades after the Nobel prize in chemistry given
to Mullis and Smith in recognition of their pioneering work on the development of the tech-
nique, biomedical and biotechnology research have advanced far beyond levels that would have
been unimaginable without it. Thermophilic organisms such as Thermus aquaticus, Pyrococcus
furiosus, and Thermococcus litoralis have provided those stable and proofreading forms of
DNA polymerases (usually referred to as Taq, Pfu, and Vent) that survive beyond the denatur-
ation temperature of long DNA fragments and, hence, have allowed the technique to become
routinely and efficiently used in all the molecular biology laboratories around the world.
A further example of the importance of extremophilic enzymes for industrial applications
can be found in the starch field. The standard process for starch conversion into single glucose
units occurs in two steps: (1) liquefaction of the raw starch granules followed by (2) saccharifi-
cation.37 The liquefaction of the raw starch granules is achieved through a necessary heating
step (105 C for 5min and 95 C for 1 h at pH 6.0) to facilitate liquefaction, and then, sacchari-
fication is done at 60 C for 3 h at pH 4.5.38 Currently, the key enzymes that are used for the
production of glucose from starch are typically a bacterial amylase and a fungal glucoamylase
combined with a pullulanase.39 Since these enzymes are not active at high temperatures and
low pH values (as needed in the second step of the process), cooling and pH adjustment is
mandatory. This energy and time consuming procedure has been optimized by the use of more
suitable extremophilic amylolytic enzymes.40 The first archaeal amylase with an optimum tem-
perature of about 100 C and residual activity at 130 C was found in P. furiosus, and it was
characterized in 1990.41 Recently, an acid-stable amylase with a half-life of 30min at 80 C was
described.42 To date, one of the most heat-active pullulanase, having an optimum temperature of
100 C, has been discovered in Thermococcus kodakarensis KOD1.43 One of the most heat-
active starch-degrading enzymes known to date is an a-amylase from Methanococcus jannaschii
(optimum temperature¼ 120 C).44
Examples of the most common enzymes that exist in thermophilic microorganisms and that,
due to their higher thermal stability compared to their mesophilic homologues, are commonly
used in high temperature biotechnology processes include cellulases, amylases, xylanases,
lipases, proteases, pectinases, and esterases. In recent years, the use of extremophiles as cellular
biocatalysts for biotransformation, in particular for biofuel production, has attracted growing
interest owing to the accelerated reaction rates, the reduced energy input, and the low contami-
nation risk that are associated with the process. Moreover, their ability to exploit different carbo-
hydrate sources (such as starch or hemicellulose) further favors the use of extremophilic species
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in industrial bioprocesses. In this field, the current main focus is on the use of starch- and
lignocellulose-degrading enzymes for the production of next-generation biofuels.
C. Nature’s strategies to achieve thermostability
Several attempts to identify those key natural features, either at the sequence or at the struc-
tural level, that provide all proteins with their signature thermostability profile have failed to
paint a clear picture and to define first principles of universal validity and general applicability.
At most, consistent trends have been described when comparing different members of specific
protein families, where a medium-to-high degree of sequence and structure similarity is often
observed. In general, thermophilic proteins are mostly made of both hydrophobic and charged
residues, showing a smaller proportion of uncharged polar residues compared to mesophilic pro-
teins. Hydrophobic residues, which usually cluster in the core of the protein to minimize solvent
exposure, form stabilizing van der Waals interactions with other hydrophobic residues, possibly
exploiting the lack of directionality that is associated with these contacts and therefore adopting
the conformation that minimizes voids in the structure while maximizing the contact surface
area. Accordingly, thermophilic proteins usually have a higher than average content of valine
(Val) and isoleucine (Ile) residues compared to mesophilic proteins.45,46 On the other hand,
properly oriented charged residues can allow the formation of stabilizing salt bridges, whose
energy contribution to the stabilization of the protein fold often exceeds that of hydrophobic
interactions. The stabilization energy provided by a single salt bridge is usually estimated to be
in the order of 3–5 kcal/mol. The need for a proper orientation of charged residues to form stabi-
lizing electrostatic interactions and, at the same time, to avoid the clustering of identical charges
highlights the limitations that are intrinsic in any thermostability analysis approach that focuses
only on residue counts and distribution within primary sequences without considering structure
level comparisons between proteins. As previously mentioned, the tendency of hydrophobic resi-
dues to cluster and shield themselves from the aqueous environment is one of the main driving
forces behind the folding and the thermal stability of a protein. Yet, within the class of hydro-
phobic residues, further stabilization is often provided when aromatic interactions (such as p-p,
cation-p, and S/p interactions) can be formed, suggesting a complex interplay between the size,
chemical nature, and electronic structure of the hydrophobic residues involved. Disulfide bond
formation resulting from two spatially closed cysteines is also an important driving force in pro-
tein folding. In fact, disulfide bridges are common in nature. The strength of the covalent bond
that is formed between two oxidized cysteines clearly provides a great deal of energy stabiliza-
tion to the fold of the protein, either locally or globally. Interestingly, Fitter and colleagues47
analyzed structural fluctuations of a-amylases from both mesophilic and thermophilic organisms,
demonstrating that in the thermophilic protein, the folded state is more structurally flexible than
the folded state of the mesophilic homologue. In contrast to the general rule that suggests that
higher structural rigidity corresponds to higher thermostability,48 in this case, higher thermosta-
bility could be the result of entropic stabilization. Altogether, these different strategies adopted
by extremophiles to achieve their superior stability can be used to guide the design and engineer-
ing of novel enzymes.
III. ENZYME STABILIZATION THROUGH DIRECTED EVOLUTION
A. Directed evolution
Directed evolution has become a fundamental strategy in protein engineering for the pro-
duction of more powerful and efficient biocatalysts.49–54 The process is similar to natural evolu-
tion, albeit on a reduced timescale. In fact, directed evolution generates, and selects under a
specific evolutionary pressure, enzymes with novel or improved features through an iterative
process characterized by several rounds of mutagenesis and screening, starting from a parental
protein. Generally, the creation of random mutants from a parental protein is done by error
prone mutagenesis,55–57 DNA shuffling,58–60 site-saturation mutagenesis,61,62 chemical mutagen-
esis,63,64 or using different mutator strains.65–67 However, all these methods generally require
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reiterative manipulation of single genes and are not used for parallel and continuous directed
evolution of gene networks or genomes. In this regard, Wang, Isaacs, and colleagues developed
the so-called Multiplex Automated Genome Engineering (MAGE) approach that, by coupling
parallel DNA synthesis and recombination in a single E. coli cell or across a population of
cells, leads to the generation of multiple modifications (mismatches, insertions, and deletions),
from single point mutations to the genome level.68,69 Due to the large size of the resulting
libraries, the ability to identify and isolate those mutants that feature the desired properties is a
critical success factor in a directed evolution campaign. To face this burden, different strategies
are adopted for library analysis and can be divided into two main methods: screening and selec-
tion. While the selection approach directly identifies the desired mutant, eliminating unproduc-
tive mutations based on a direct connection between cell growth and an optimized or acquired
enzyme function, in a screening method, all the resulting variants from the library are individu-
ally tested for the desired function, minimizing the risk of false negatives. However, the weak-
ness of this method lies in the reduced number of mutants that can be evaluated, which makes
automation a necessary and key element for a rapid high-throughput screening approach.
Microtitre plate- and agar plate-based screening procedures are the two most commonly
adopted library screening formats. Compared to the latter, microtitre plate-based assays are suit-
able for handling large libraries of mutants and use a smaller quantity of the sample. Generally,
an enzyme activity assay is performed on crude lysate from single colonies, or on purified pro-
teins, into multi-well plates (e.g., from 96 to 9600-well). The use of classical colorimetric or
fluorescence assays allows the verification of any small improvements in the desired function or
property of the enzyme.70–73 However, the use of these assays is restrained only to those cases
where substrates, cofactors, or products are suitable for UV-vis absorbance or fluorescence
measurements. In order to overcome this limitation, a variety of analytical techniques can be
implemented within a high-throughput format. Examples include automated systems using
on-line high performance liquid chromatography (HPLC)74 or mass spectrometry (MC)75 for
direct product quantitation. Agar plate-based screening methods focus on the direct correlation
between the growth of the host organism on selective agar plates for the screening of a specific
enzyme function.56,76,77 Here, colonies displaying a desired color within a certain time window
are selected as active. Despite the outstanding performance of this approach for the direct
detection of the desired mutant, its lower sensibility in the estimation of the enzymatic activity
represents its main limitation compared to a microtitre plate-based screening method.
Therefore, in order to identify significantly improved enzyme variants, it is common to couple
an agar plate assay as a primary screen with a secondary activity assay, generally set up in a
96-well microtiter plate and based on a biochemical assay.78 Microtitre plate- and agar plate-
based screens are powerful methods for library analysis; however, relative to the size of com-
plete libraries (108–109 mutants), their efficiency is relatively low (104/day for the microtitre
plate and 105/day for the agar plate). Interestingly, fluorescence-activated cell sorting (FACS)
provides a high-throughput approach directly on a cell population (108/day), for the direct
separation of mutants expressing the desired protein, where the link between the genotype
(mutation) and the phenotype (desired property) is maintained through a fluorescence assay that
detects those cells that display that particular enzymatic activity.79 Different strategies can be
adopted, generally based on the detection of the product either inside the cell (product entrap-
ment)80 or onto the surface of cells (cell surface display).81 Both these methods can be classi-
fied as in vivo methods. A FACS-based in vitro approach, usually referred to as in vitro
compartmentalization, involves compartmentalization of the gene encoding the mutant protein
in small aqueous droplets, together with the fluorescent product of interest.82 In practice, a
directed evolution campaign can be separated into three well-defined steps: the identification of
a good starting parental protein, the creation of a library of mutants, and the screening or selec-
tion step, based on the artificial selection imposed to identify improved mutants that carry out a
specific function. This entire process of mutant generation and isolation is repeated until the
desired change is observed, and it can be iterated over the resulting mutant from a previous
cycle until no further change is elicited (Fig. 1). It is generally believed that the use of a con-
sensus sequence that is either based on a protein family of interest or closer to the protein
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ancestor will likely define the most stable starting scaffold to be used in a directed evolution
campaign, and it will be more tolerant to the deleterious effects of mutations or insertions.
Indeed, protein families that are characterized by substrate ambiguity (i.e., are active on a wider
range of substrates) or catalytic promiscuity (i.e., catalyze different types of reactions) are more
suitable for a directed evolution campaign.83–88 Clearly, directed evolution represents a power-
ful and effective approach for reshaping the basic characteristics of enzymes or for designing
de novo enzymes in order to improve not only their catalytic features (e.g., optimization of
kinetic parameters) but also their stability (e.g., thermal and pH stabilities) or protein yield pro-
duction for subsequent industrial applications.
B. Thermostable enzymes by directed evolution
Several examples of thermal stabilization obtained by directed evolution can be found in
the literature. For instance, improvements in the thermostability of galacto-N-biose/lacto-N-
biose I phosphorylase (GLNBP) from Bifidobacterium longum JM1217 were achieved by
directed evolution.89 From the initial library of GLNBP mutants, two single mutants were
selected, showing each a significant improvement relative to the wild type (10 C). Based on
these results, the corresponding double mutant was generated and shown to exhibit a 20 C
higher thermostability than the wild type, allowing its use for the industrial production of LNB
at high temperature, thus resulting in the shortening of the reaction time and in the prevention
of microbial contamination. A study reporting the enhancement in the thermostability of an
amylase from Thermus sp. strain IM6501 (ThMA) well represents the compromises that can be
faced in a directed evolution experiment, showing how an improvement in thermostability can
affect catalytic efficiency.90,91 Indeed, the resulting thermostable mutant ThMA, which features
a total of seven single mutations, exhibits a 15 C increase in the optimal reaction temperature
relative to the wild type enzyme. However, one of the mutations reduces the activity of the
enzyme by 23% relative to the wild type form, still preserving significant thermoresistance.92
Another example of thermoresistance improvement by directed evolution for industrial applica-
tions comes from the endo-b-1,4-xylanase (XynA) from Thermomyces lanuginosus.93 Here,
based on a first campaign of directed evolution, four mutants, which were selected based on the
exhibited improvement of activity and stability, were subjected to further rounds of mutagene-
sis. The majority of the resultant mutants exhibited the expected compromise between stability
and activity, and only one of these second generation mutants showed a significant improve-
ment in activity and stability relative to the wild type enzyme. It is worth stressing that directed
FIG. 1. Directed evolution campaign. An iterative mutagenesis and screening process is performed starting from the gene
coding for the enzyme of interest. From the generated mutant library, mutants are screened for the desired function or prop-
erty. The best performing mutant can then be used as the parental gene for the next iterative rounds of mutagenesis.
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evolution experiments can target not only high thermostability improvements, as described
above. For instance, aggregation can significantly influence the yield and the biological activity
of biopharmaceutical products.94 For example, antibody stabilization is a critical issue for
industry. Aggregation-resistant antibodies, showing a 2–3 C increase compared to the wild
type, have been developed by directed evolution in order to improve antigen-binding fragment
(Fab) stability.95 Another example involving a combination of rational design and directed
evolution is that of an extremely stable green fluorescent protein, eCGP123, which was created
by a consensus engineering approach or consensus green protein (CGP).96 The process con-
sisted of a recursive iteration involving the sequential introduction of three destabilizing heter-
ologous inserts, a sequential mutagenesis step to overcome the destabilization, and the final
removal of the destabilizing insert from the mutated gene.97
IV. ENZYME STABILIZATION THROUGH RATIONAL DESIGN
The vast majority of mutations in a natural enzyme destabilize.98 Nonetheless, a naturally
occurring enzyme is not necessarily the most stable form that is possible for that specific
enzyme. Indeed, some mutations can further stabilize a protein, increasing the equilibrium pop-
ulation of the folded state.83,99 In a directed evolution campaign, whereby random mutations
are introduced in the coding gene and the large resulting libraries (typically consisting of more
than 105 variants) are screened for a specific function, mutant enzymes featuring improved
thermostability can most likely be identified.100,101 Unfortunately, such a random approach is
possible only with enzymes for which fast activity screens can be implemented. While directed
evolution has yielded improved enzyme variants, it is a time-consuming and highly labor-
intensive method, often leading to a dead-end, where further introduction of function-altering
mutations is limited by low enzyme stability.102
A. Rational design
The modification of the properties of an enzyme could be achieved through the use of dif-
ferent rational approaches. Over the past few years, computational design has been successfully
applied for the thermostabilization of noncatalytic proteins, the first notable examples being
represented by the computational stabilization of a cytokine analog in 2002 by Luo and col-
leagues.103 However, the stabilization of an enzyme presents additional challenges. Indeed, the
geometry of the active site and the protein dynamic behavior during an enzymatic reaction
are often crucial for providing the maximum catalytic efficiency. Therefore, rational design meth-
ods need to be able to predict stabilizing mutations in the context of a given fold and, at the same
time, minimize any change in the backbone conformation that might disrupt the structure of the
active site or reduce its flexibility. Recently, several different in silico methods to establish the
effect of mutations on the stability of a protein have been developed.104,105 Nonetheless, the reli-
ability of these approaches is still unsatisfactory.106 The techniques used to increase protein stabil-
ity with a rational approach are often based on one or multiple methods including phylogenetic
analysis,107 comparison to homologous proteins (and particularly thermophiles),108 optimization of
charged interactions (salt bridges and hydrogen bonds), optimization of residues and loops showing
unfavorable Ramachandran angles and high B-factors,109 methods based on the calculation of free
energies,110 and structure-based computational design.111,112
Several rational design strategies can be implemented to improve enzyme thermal resis-
tance (see Fig. 2). One of the most common methods used since the dawn of protein engineer-
ing is the introduction of disulfide bridges,113,114 which usually provide considerable stability to
proteins by locking their fold in a well-defined local or global conformation.115,116 Other com-
mon strategies involve the introduction of surface hydrogen bonds117 and salt-bridges118 that
enhance protein stability by increasing protein rigidity and decreasing free energy. Indeed, an
increased number of surface hydrogen bonds and salt bridges are often observed in thermophilic
proteins, where they contribute to thermal stability. In mobile loops, the introduction of
prolines119 provides an increase in stability by reducing the entropy of the denatured state.
Further rational engineering strategies focus on the design of well-packed hydrophobic cores,111
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which play a central role in preserving enzyme stability and conformational specificity. Finally,
phylogenetic analysis is often used to guide rational design.120 Specifically, this kind of analysis
helps in disfavoring uncommon residues for a specific position or favoring common ones (espe-
cially those found in thermophiles).
B. Computational screening
Proteins may often acquire an improved stability via the introduction of several mutations.
However, sometimes, a single severely destabilizing mutation is sufficient to totally disrupt a
protein fold, even in the presence of several stabilizing ones. Therefore, high prediction accu-
racy is essential. Unfortunately, all the existing methods have a relatively high probability of
introducing unfavorable mutations.111,121 Therefore, protein stabilization can more safely pro-
ceed only via the incorporation of a very limited number of predicted stabilizing mutations at
each mutagenesis step. Alternatively, phylogenetic libraries can be used to identify optimal
combinations of stabilizing mutations.122–124 However, both these approaches are labor-
intensive and applicable only to those proteins for which well-established medium-to-high
throughput screens are available. Recent methods include computational high-throughput
screening methods to evaluate libraries of potentially stabilizing mutations.125,126
C. Notable achievements
The earliest notable example of rational design for enzyme thermostabilization is the work
of Baker and coworkers in 2005,127 in which they used Rosetta to stabilize a cytosine deami-
nase, an enzyme with potential use for antitumoral strategies. In this work, an energy function
was used to evaluate target sequences threaded onto a fixed backbone. Using an iterative heuris-
tic procedure followed by an energy evaluation step, a comprehensive search of the space
sequence was done. While the adoption of those sequences associated with the lower energy
values was automatic, the higher energy sequences were assigned a probability based on the
Rosetta score. The authors identified three mutations that, when combined, produced a remark-
able increase in enzyme stability. Following this seminal work, several other researchers intro-
duced various computational approaches aimed at improving the stability of enzymes that are
relevant for different industrial applications. Table II summarizes the key achievements in the
field.
FIG. 2. Stabilizing strategies used in rational enzyme design. The most common strategies involve the introduction of sur-
face hydrogen bonds (a) and salt bridges (b), the stabilization of the hydrophobic core (c), the introduction of disulfide brid-
ges (d), and the stabilization of mobile loops using prolines (e). Phylogenetic analysis (f) can be used alone or in
combination with previous strategies to guide the enzyme rational design process.
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TABLE II. Notable examples of rational design of enzymes with industrial applications.
Enzyme Application Method Stabilization achieved References
Cytosine deaminase Possible antitumoral Rosetta Tm increases up to 10
C Korkegian127
Glucose dehydrogenase Commodity chemical biosynthesis Structure-guided consensus analysis Tm increases up to 34
C Vazquez-Figueroa et al.128
Proteinase K Molecular biology Phylogenetic analysis and machine
learning design
20X half-life at 68 C Liao et al.129
Cocaine esterase Pharmaceutical industry Molecular d and Rosetta 30X half-life at 37 C Gao et al.130
Xylanase Production of paper Flexible region stabilization and
Rosetta
15X half-life at 50 C Joo et al.131
Lipase Detergents, food, bioenergy, and
pharmaceuticals
B-factor analysis and Rosetta Tm increases by 2
C Kim et al.132
Terpene synthase Production of terpenoids Statistical, computationally assisted
design strategy (SCADS) algorithm
Tm increases up to 40
C Diaz et al.133
Lipase Detergents, food, bioenergy, and
pharmaceuticals
Consensus analysis 2X half-life in organic solvents Park et al.134
Lipase Detergents, food, bioenergy, and
pharmaceuticals
Disulfide by Design code Tm increases by 7
C Yu et al.135
Methyl parathion hydrolase Detoxification of pesticides Unfolding free energy (Prethermut
code)
Tm increases by 12
C, and T50 increases
by 10 C
Tian et al.136
Pullulanase (a-amylase) Production of high-glucose syrup Structure-guided consensus analysis 4.3X half-life at 60 C Duan et al.137
Limonene epoxide hydrolase Production of chiral building blocks Rosetta, Dynamic Disulfide
Discovery, and Molecular
Dynamics
Tm increases up to 35
C and increased
activity
Wijma et al.126
Cellulase Cellulose degradation Salt bridge design Tm increases by 16
C Lee et al.138
3-dehydroshikimate dehydratase Commodity chemical biosynthesis Visual inspection, Rosetta, and void
identification and packing (VIP)
server
10X higher half-life at 37 C and
increased expression
Harrington et al.139
Phytase Phytate degradation Disulfide by Design code 3X higher half-life at 60 C Tan et al.140
Cutinase Polymer degradation Rosetta Tm increases by 6
C, 10X higher half-
life at 60 C
Shirke et al.141
Acetylcholinesterase Detoxification of pesticides and
nerve agents
Rosetta and Phylogenetic analysis Tm increases by 20
C and increased
expression
Goldenzweig et al.125
Transketolase Synthesis of complex carbohydrates Rosetta and consensus analysis Tm increases by 5
C and increased kcat Yu et al.
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D. Rational enzyme design algorithms
In the past few years, several procedures have been developed to design thermostable
enzymes. Two of them appear to be particularly promising given their general applicability,
integration of orthogonal methods, and ease of use.
E. FRESCO
The “Framework for Rapid Enzyme Stabilization by Computational libraries”
(FRESCO),126 developed by the Janssen group at the University of Groningen, follows five
major steps. In the first step (1), a library of single point mutations is generated using Rosetta,
FoldX, and an in-house code for disulfide discovery, eventually excluding the catalytic region
from mutable residues. The mutations are retained in the library if they provide a stabilizing
effect based on internal scoring. The second step (2) involves the elimination of unreasonable
mutations upon visual inspection. The major reasons for elimination are hydrophobic side
chains exposed to solvent or proline residues introduced inside an a-helix. The third step (3)
involves the screening of the mutant library with molecular dynamics (MD) simulations and
then filtering out mutations that lead to an increase in root mean square fluctuations. The
assumption for this step is that mutations that increase structural flexibility with respect to the
wild type are likely to be destabilizing. After the MD-based screening, in step (4), surviving
mutations are experimentally tested to verify that they provide an actual increase in melting
temperature while preserving catalytic activity. At this stage, a library of experimentally vali-
dated stabilizing single-point mutations is obtained. In step (5), the validated single-point muta-
tions are combined, screened with MD simulations and then experimentally validated, providing
the final stabilized variant(s) of the enzyme.
The two major advantages of FRESCO are the use of different strategies and methods to
generate the initial library of mutations and the use of orthogonal methods to filter them (i.e.,
Rosetta/FoldX scoring followed by MD). On the other hand, usability and automation are lim-
ited, given that step (2) involves visual inspection. A second possible drawback is that the ini-
tial stage includes the screening of only single-point mutations. Indeed, it is possible that two
single-point mutations, when considered alone, are found to be destabilizing, whereas, if com-
bined, they could generate stabilizing interactions.
F. PROSS
A second promising framework for enzyme stabilization is the “Protein Repair One Stop
Shop” (PROSS)125 developed by the Fleishman Lab at Weizmann Institute of Science. In the
first step (1), the algorithm performs a sequence alignment with homologous proteins. Rather
than selecting the most promising mutations for each position, this step is performed to elimi-
nate the mutations that are rare or not observed. The second step (2) involves the use of
Rosetta to evaluate potentially stabilizing mutations, selecting only those that provide an energy
decrease with respect to the wild type. Finally, in the third step (3), the single point mutations
that have been selected in the previous step are combined and the enzyme variants are ranked
based on their energy score.
A major advantage of PROSS is its ease of use, either reproducing the algorithm in-house
or employing the web-server developed by the authors (http://pross.weizmann.ac.il). On the
other hand, a possible major limitation of this approach is the lack of orthogonal methods (e.g.,
MD) in combination with Rosetta. A further limitation is the need for several homologs of the
target protein in order to increase the reliability of the first step of the algorithm.
G. Outlook for rational enzyme engineering
In the last 60 years, protein science has moved from the first success in protein structure
determination (the Myoglobin X-ray crystal structure in 1958)143 to the early attempts at protein
engineering (the design of a reduced ribonuclease in 1979).144 The introduction of
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computational analysis methods led to the de novo design of a protein motif in 1997,145 boost-
ing our ability to engineer proteins (see Fig. 3). The possibility of building new proteins, tuning
enzyme catalytic activity, and extending their thermal stability is now increasingly exploited for
different industrial applications. Protein design is often termed “the inverse folding problem”
because when our ability to build or modify a protein in a predictable way will finally be
attained, which will provide an indirect evidence that the protein folding problem is well-
understood. Therefore, the methods and successes of enzyme engineering contribute directly to
those of protein structure prediction.
A general major limitation of current computational enzyme design approaches is the lack
of an objective assessment of the different available methods, similar to the one used in the
Critical Assessment of Structure Prediction (CASP) competition.146 Within the CASP challenge,
research groups have the opportunity to test their structure prediction methods by identifying a
protein structure from its amino acid sequence. The assessors are not part of the competitors,
thus enabling objective analysis of achievements and challenges in a comparative manner.
Without a similar community-wide objective assessment, the comparative analysis of computa-
tional design methods necessarily relies upon reports by the respective authors of each method,
thus hampering the identification of advantages and disadvantages of each tool and the cross-
dissemination of knowledge.
A further major challenge in the field of enzyme engineering is the accessibility to the gen-
eral scientific community. Until now, computational enzyme design lacked standardization and
solid reliability of results. As such, it has not been carried out by a large community, but rather
it has clustered in a small number of labs leading the field. Most often, these are the laborato-
ries where software packages are developed. As with other fields, it is expected that with time,
more and more scientists will apply computational enzyme design, and rational design will
become a standardized and common procedure carried out on a routine basis in biochemical
laboratories.
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